329 related articles for article (PubMed ID: 9260011)
1. Neostigmine requirements for reversal of neuromuscular blockade following an infusion of mivacurium.
Lessard MR; Trépanier CA; Rouillard JF
Can J Anaesth; 1997 Aug; 44(8):836-42. PubMed ID: 9260011
[TBL] [Abstract][Full Text] [Related]
2. To reverse or not to reverse: an evaluation of reversal of mivacurium chloride in women undergoing outpatient gynecological procedures.
Jahr JS; Keller T; Williams MD; Liukkonen JR; Anwar M; Paxtor CG; Greene M; Gitlin MC
Am J Ther; 1997; 4(9-10):315-22. PubMed ID: 10423625
[TBL] [Abstract][Full Text] [Related]
3. The reversal of profound mivacurium-induced neuromuscular blockade.
Kao YJ; Le ND
Can J Anaesth; 1996 Nov; 43(11):1128-33. PubMed ID: 8922768
[TBL] [Abstract][Full Text] [Related]
4. Intubating conditions and neuromuscular block after divided dose mivacurium or single dose rocuronium.
Patel N; Kamath N; Smith CE; Pinchak AC; Hagen JH
Can J Anaesth; 1997 Jan; 44(1):49-53. PubMed ID: 8988824
[TBL] [Abstract][Full Text] [Related]
5. Reversal of mivacurium chloride: edrophonium of spontaneous recovery in microscopic laryngeal surgery.
Ting CK; Lin SM; Yang YW; Tsai HJ; Lao HC; Chu YC; Tsai SK
Acta Anaesthesiol Sin; 2001 Dec; 39(4):157-62. PubMed ID: 11840581
[TBL] [Abstract][Full Text] [Related]
6. Neostigmine but not edrophonium prolongs the action of mivacurium.
Symington MJ; Mirakhur RK; Kumar N
Can J Anaesth; 1996 Dec; 43(12):1220-3. PubMed ID: 8955970
[TBL] [Abstract][Full Text] [Related]
7. Mivacurium chloride (BW B1090U)-induced neuromuscular blockade during nitrous oxide-isoflurane and nitrous oxide-narcotic anesthesia in adult surgical patients.
Weber S; Brandom BW; Powers DM; Sarner JB; Woelfel SK; Cook DR; Foster VJ; McNulty BF; Weakly JN
Anesth Analg; 1988 Jun; 67(6):495-9. PubMed ID: 2967644
[TBL] [Abstract][Full Text] [Related]
8. Sugammadex provides faster reversal of vecuronium-induced neuromuscular blockade compared with neostigmine: a multicenter, randomized, controlled trial.
Khuenl-Brady KS; Wattwil M; Vanacker BF; Lora-Tamayo JI; Rietbergen H; Alvarez-Gómez JA
Anesth Analg; 2010 Jan; 110(1):64-73. PubMed ID: 19713265
[TBL] [Abstract][Full Text] [Related]
9. Sugammadex reversal of rocuronium-induced neuromuscular blockade: a comparison with neostigmine-glycopyrrolate and edrophonium-atropine.
Sacan O; White PF; Tufanogullari B; Klein K
Anesth Analg; 2007 Mar; 104(3):569-74. PubMed ID: 17312210
[TBL] [Abstract][Full Text] [Related]
10. Antagonism of low degrees of atracurium-induced neuromuscular blockade: dose-effect relationship for neostigmine.
Fuchs-Buder T; Meistelman C; Alla F; Grandjean A; Wuthrich Y; Donati F
Anesthesiology; 2010 Jan; 112(1):34-40. PubMed ID: 19952724
[TBL] [Abstract][Full Text] [Related]
11. [Effects of different doses of edrophonium antagonism of mivacurium-induced neuromuscular block in the presence of nitrous oxide, propofol, and alfentanil anesthesia].
Ripart J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1996 Apr; 43(4):368-72. PubMed ID: 8697552
[TBL] [Abstract][Full Text] [Related]
12. Antagonism of profound cisatracurium and rocuronium block: the role of objective assessment of neuromuscular function.
Kopman AF; Kopman DJ; Ng J; Zank LM
J Clin Anesth; 2005 Feb; 17(1):30-5. PubMed ID: 15721727
[TBL] [Abstract][Full Text] [Related]
13. Pharmacodynamics and the plasma concentration of mivacurium during spontaneous recovery and neostigmine-facilitated recovery.
Lien CA; Belmont MR; Wray Roth DL; Okamoto M; Abalos A; Savarese JJ
Anesthesiology; 1999 Jul; 91(1):119-26. PubMed ID: 10422936
[TBL] [Abstract][Full Text] [Related]
14. Dose-response relationships for edrophonium antagonism of mivacurium-induced neuromuscular block during N2O-enflurane-alfentanil anaesthesia.
Marcotte J; Drolet P; Perreault L; Girard M
Can J Anaesth; 1995 Oct; 42(10):879-83. PubMed ID: 8706197
[TBL] [Abstract][Full Text] [Related]
15. Dose responses for neostigmine and edrophonium as antagonists of mivacurium in adults and children.
Bevan JC; Tousignant C; Stephenson C; Blackman L; Reimer E; Smith MF; Bevan DR
Anesthesiology; 1996 Feb; 84(2):354-61. PubMed ID: 8602666
[TBL] [Abstract][Full Text] [Related]
16. Antagonism of mivacurium-induced neuromuscular blockade in humans. Edrophonium dose requirements at threshold train-of-four count of 4.
Kopman AF; Mallhi MU; Justo MD; Rodricks P; Neuman GG
Anesthesiology; 1994 Dec; 81(6):1394-400. PubMed ID: 7992908
[TBL] [Abstract][Full Text] [Related]
17. Comparison of tracheal intubating conditions and neuromuscular blocking profiles after intubating doses of mivacurium chloride or succinylcholine in surgical outpatients.
Goldberg ME; Larijani GE; Azad SS; Sosis M; Seltzer JL; Ascher J; Weakly JN
Anesth Analg; 1989 Jul; 69(1):93-9. PubMed ID: 2525886
[TBL] [Abstract][Full Text] [Related]
18. Effect of neostigmine at different levels of mivacurium-induced neuromuscular blockade.
Trévien V; Lienhart A; Just B; Chandon M; Baras E; Camatte S
Acta Anaesthesiol Scand Suppl; 1995; 106():66-9. PubMed ID: 8533550
[TBL] [Abstract][Full Text] [Related]
19. Neuromuscular and clinical effects of mivacurium chloride in healthy adult patients during nitrous oxide-enflurane anaesthesia.
Goldhill DR; Whitehead JP; Emmott RS; Griffith AP; Bracey BJ; Flynn PJ
Br J Anaesth; 1991 Sep; 67(3):289-95. PubMed ID: 1832920
[TBL] [Abstract][Full Text] [Related]
20. Enzymatic versus pharmacologic antagonism of profound mivacurium- induced neuromuscular blockade.
Naguib M; Selim M; Bakhamees HS; Samarkandi AH; Turkistani A
Anesthesiology; 1996 May; 84(5):1051-9. PubMed ID: 8623998
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]